Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $255.0.

  • Mangoceuticals' Depreciation and Depletion rose 119.05% to $255.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1012.0, marking a year-over-year decrease of 9366.39%. This contributed to the annual value of $9936.0 for FY2024, which is 6007.87% down from last year.
  • Latest data reveals that Mangoceuticals reported Depreciation and Depletion of $255.0 as of Q3 2025, which was up 119.05% from $252.0 recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' Depreciation and Depletion ranged from a high of $6292.0 in Q3 2023 and a low of $250.0 during Q1 2025
  • Over the past 3 years, Mangoceuticals' median Depreciation and Depletion value was $3205.0 (recorded in 2024), while the average stood at $3234.7.
  • Within the past 5 years, the most significant YoY rise in Mangoceuticals' Depreciation and Depletion was 233.48% (2024), while the steepest drop was 9599.49% (2024).
  • Over the past 3 years, Mangoceuticals' Depreciation and Depletion (Quarter) stood at $6291.0 in 2023, then tumbled by 95.95% to $255.0 in 2024, then changed by 0.0% to $255.0 in 2025.
  • Its last three reported values are $255.0 in Q3 2025, $252.0 for Q2 2025, and $250.0 during Q1 2025.